Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare CNSX:ATT NASDAQ:PCT On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeATTAbattis BioceuticalsC$0.00C$0.05▼C$0.74N/AN/A1.42 million shsN/APCTPureCycle Technologies$8.88-1.6%$9.24$4.93▼$17.37$1.61B2.486.22 million shs8.48 million shsThe 7 Hottest IPOs On Wall Street’s 2026 WatchlistMarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceATTAbattis Bioceuticals0.00%0.00%0.00%0.00%0.00%PCTPureCycle Technologies-1.55%-29.07%-12.94%+54.17%-20.71%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeATTAbattis BioceuticalsC$0.00C$0.05▼C$0.74N/AN/A1.42 million shsN/APCTPureCycle Technologies$8.88-1.6%$9.24$4.93▼$17.37$1.61B2.486.22 million shs8.48 million shsThe 7 Hottest IPOs On Wall Street’s 2026 WatchlistMarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceATTAbattis Bioceuticals0.00%0.00%0.00%0.00%0.00%PCTPureCycle Technologies-1.55%-29.07%-12.94%+54.17%-20.71%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceATTAbattis Bioceuticals 0.00N/AN/AN/APCTPureCycle Technologies 2.50Moderate Buy$11.0023.87% UpsideCurrent Analyst Ratings BreakdownLatest ATT, SDR, MNG, and PCT Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/12/2026PCTPureCycle Technologies Northland SecuritiesSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price Target$13.006/5/2026PCTPureCycle Technologies Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)5/8/2026PCTPureCycle Technologies TD CowenSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetHold$7.00 ➝ $6.00(Data available from 6/13/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookATTAbattis BioceuticalsN/AN/AN/AN/AN/AN/APCTPureCycle Technologies$8.35M192.34N/AN/A$0.25 per share35.52Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateATTAbattis BioceuticalsN/AN/AN/AN/AN/AN/AN/AN/AN/APCTPureCycle Technologies-$182.57M-$1.47N/AN/AN/A-2,062.36%-393.01%-22.56%8/6/2026 (Estimated)Latest ATT, SDR, MNG, and PCT EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/6/2026Q1 2026PCTPureCycle Technologies-$0.26-$0.21+$0.05-$0.21$3.83 million$4.13 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthATTAbattis BioceuticalsN/AN/AN/AN/AN/APCTPureCycle TechnologiesN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioATTAbattis BioceuticalsN/AN/AN/APCTPureCycle Technologies47.591.711.57Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipATTAbattis BioceuticalsN/APCTPureCycle Technologies63.01%Insider OwnershipCompanyInsider OwnershipATTAbattis BioceuticalsN/APCTPureCycle Technologies18.80%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableATTAbattis BioceuticalsN/AN/AN/ANot OptionablePCTPureCycle Technologies120180.86 million146.86 millionNot OptionableATT, SDR, MNG, and PCT HeadlinesRecent News About These CompaniesPureCycle shares slide after company prices $250M notes, $145M stock offeringJune 11 at 5:13 PM | msn.comPureCycle Technologies falls on planned $145M stock sale and $250M convertible notes offeringJune 11 at 10:50 AM | quiverquant.comQWhy is PCT stock falling 14% premarket today?June 11 at 7:07 AM | msn.comPureCycle Launches Major Convertible Notes and Equity OfferingsJune 11 at 6:51 AM | tipranks.comPureCycle Announces Pricing of Concurrent Public Offerings of 4.75% Convertible Senior Notes Due 2032 and Common Stock with Aggregate Gross Proceeds of $395.0 MillionJune 11 at 1:29 AM | globenewswire.comPureCycle Technologies, Inc. Announces $395 Million Public Offerings of Convertible Senior Notes and Common StockJune 10 at 4:50 PM | quiverquant.comQPureCycle Announces Proposed Concurrent Public Offerings of Convertible Senior Notes and Common StockJune 10 at 4:50 PM | markets.businessinsider.comPureCycle Announces Proposed Concurrent Public Offerings of Convertible Senior Notes and Common StockJune 10 at 4:35 PM | globenewswire.comPureCycle, Innovia Films Partner to Successfully Produce White, Cavitated BOPP Film Using PureFive Choice™ Recycled PolypropyleneJune 9, 2026 | theglobeandmail.comPureCycle Technologies and Innovia Films Achieve Milestone in Recycled BOPP Film ProductionJune 9, 2026 | quiverquant.comQPureCycle, Innovia Films Partner to Successfully Produce White, Cavitated BOPP Film Using PureFive Choice™ Recycled PolypropyleneJune 9, 2026 | globenewswire.comIs PureCycle Technologies, Inc. (PCT) A Good Stock To Buy Now?June 7, 2026 | finance.yahoo.comPureCycle Technologies, Inc. (NASDAQ:PCT) Receives Consensus Rating of "Moderate Buy" from AnalystsJune 4, 2026 | americanbankingnews.comPureCycle (PCT) Adds 6% on PureFive Living Hinge Cap SuccessJune 3, 2026 | insidermonkey.comPureCycle and StackTeck Successfully Produce Living Hinge Cap Using PureFive® Recycled PolypropyleneJune 3, 2026 | globenewswire.comAssessing PureCycle Technologies (PCT) Valuation After Its Sharp Recent Share Price RallyJune 2, 2026 | finance.yahoo.comShort Sellers Are Hammering These 10 Stocks — One Is 86% ShortMay 28, 2026 | benzinga.comPureCycle Achieves ISO 9001:2015 Certification, Demonstrating Operational Maturity and Customer Readiness at ScaleMay 28, 2026 | globenewswire.comPureCycle Technologies is the best performing material stock in the past monthMay 27, 2026 | msn.comPureCycle (Thailand) Admitted to Thailand’s FastPass Investment Acceleration ProgramMay 26, 2026 | markets.businessinsider.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesSpaceX Gets the Attention, But These 4 Stocks Could Get the ReturnsBy Bridget Bennett | May 25, 20263 Rare Earth Stocks That Win No Matter What China Does NextBy Bridget Bennett | May 24, 2026Microsoft Stock Discount May Be Ending as AI Catalysts BuildBy Chris Markoch | May 25, 2026From Zepbound to Foundayo: Lilly's Latest Results Support Oral GLP-1 OutlookBy Leo Miller | May 20, 2026Vertical Aerospace: Pre-Flight Checks Point to a BreakoutBy Jeffrey Neal Johnson | May 20, 2026ATT, SDR, MNG, and PCT Company DescriptionsAbattis Bioceuticals CNSX:ATTAbattis Bioceuticals Corp. is a specialty biotechnology company. The Company aggregates, incubates, integrates and invests in the natural health product and botanical drug development industry. It operates through the segment of producing, licensing and marketing ingredients and formulas for use in the biopharma, nutraceutical, cosmetic and animal nutrition markets. The Company, through its subsidiaries, develops and commercializes natural health (nutraceutical) products, and conducts research and development to create plant-based (botanical) intellectual property and ingredients for the pharmaceutical and bioceutical markets, among others. It offers products and services, such as botanical blends and formulas; cannabidiol ingredients; functional foods and beverages, and analytical services. It is focused on creating botanical formulations, medical marijuana and specialized health products for pain caused by inflammation, and mental ailments.PureCycle Technologies NASDAQ:PCT$8.88 -0.14 (-1.55%) Closing price 06/12/2026 04:00 PM EasternExtended Trading$8.88 -0.01 (-0.06%) As of 06/12/2026 07:46 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.PureCycle Technologies, Inc. engages in the production of recycled polypropylene (PP). The company holds a license for restoring waste PP into ultra-pure recycled polypropylene resin that has multiple applications, including packaging and labeling for consumer products, piping, ropes, cabling, and plastic parts for various industries. Its recycling process separates color, odor, and other contaminants from plastic waste feedstock to transform it into virgin-like resin. The company was founded in 2015 and is headquartered in Orlando, Florida. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas SpaceX Rings the Bell and Shatters Every Record Adobe Stock Just Got Cheaper—Is Wall Street Missing the Story? ERock IPO: A $1.3B Power Play Solution TJX: Retail’s Apex Predator Feasts on Inflation Boeing’s Unseen Rebound: Why the Headlines Are Wrong Why Oracle's 10% Drop May Be Telling the Wrong Story Spotify's "North Star" Outlook Was Music to Investors Ears This Energy Stock Has Quietly Soared 130% in a Year Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
